TrialPloS one2013

Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia.

Janin Nouhin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.